H35.38
Toxic maculopathy
Clinical Classification Guidelines
Use Additional Code
- code for adverse effect, if applicable, to identify drug (T36-T50 with fifth or sixth character 5)
Code First
- poisoning due to drug or toxin, if applicable (T36-T65 with fifth or sixth character 1-4)
Medical Intelligence & Overview
Toxic maculopathy is a condition characterized by damage to the macula, the central part of the retina responsible for sharp, detailed vision. This damage results from exposure to toxic substances that adversely affect the retinal tissues. Recognizing the signs, causes, and treatment options for toxic maculopathy is vital for early intervention and preserving vision. Although it is a rare condition, understanding its implications can help individuals at risk to seek timely medical evaluation.
Causes & Symptoms
Clinical Causes: Prolonged exposure to retinal-toxic medications, such as certain antibiotics (e.g., chloroquine and hydroxychloroquine) Ingestion or application of harmful toxins or chemicals that reach ocular tissues Heavy metal poisoning, including arsenic or mercury exposure Use of certain drugs that can induce retinal toxicity Accidental or intentional exposure to toxic substances in the environment or workplace
Key Symptoms: Decreased central vision or blurred vision Distorted vision (e.g., straight lines appearing curved) Presence of a central scotoma (a dark or blind spot in the visual field) Difficulty reading or recognizing faces Color perception changes, especially in the central retina Possible visual field defects depending on severity
Diagnostic & Treatment
Diagnosis Path: Diagnosis of toxic maculopathy involves a comprehensive eye examination including retinal imaging. Diagnostic tools may include:
Treatment Protocols: Management of toxic maculopathy primarily focuses on cessation of the causative toxin or medication. Additional intervention may include:
Clinical Advice & FAQs
Billing Guidance
Is H35.38 a billable ICD-10 code?
Yes, H35.38 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report H35.38?
Clinical documentation must specify the nature of Toxic maculopathy and any associated comorbidities for accurate reporting.
Cite this Clinical Reference